TrialAntimicrobial agents and chemotherapy2026
Phase I dose-ascending, safety, and pharmacokinetics study of APC148, a novel metallo-β-lactamase inhibitor, in healthy volunteers.
Bjørg Bolstad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.